PT1031575E - Processo para preparacao de indutores de secrecoes da hormona de crescimento - Google Patents

Processo para preparacao de indutores de secrecoes da hormona de crescimento

Info

Publication number
PT1031575E
PT1031575E PT00301526T PT00301526T PT1031575E PT 1031575 E PT1031575 E PT 1031575E PT 00301526 T PT00301526 T PT 00301526T PT 00301526 T PT00301526 T PT 00301526T PT 1031575 E PT1031575 E PT 1031575E
Authority
PT
Portugal
Prior art keywords
secrecous
inductors
preparation
growth hormone
hormone
Prior art date
Application number
PT00301526T
Other languages
English (en)
Inventor
Frank Robert Busch
Charles Kwok-Fung Chiu
Clifford Nathaniel Meltz
Ronald James Post
Peter Robert Rose
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PT1031575E publication Critical patent/PT1031575E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT00301526T 1999-02-26 2000-02-25 Processo para preparacao de indutores de secrecoes da hormona de crescimento PT1031575E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (1)

Publication Number Publication Date
PT1031575E true PT1031575E (pt) 2004-11-30

Family

ID=22404505

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00301526T PT1031575E (pt) 1999-02-26 2000-02-25 Processo para preparacao de indutores de secrecoes da hormona de crescimento

Country Status (44)

Country Link
US (2) US6541634B2 (pt)
EP (2) EP1031575B1 (pt)
JP (3) JP3437813B2 (pt)
KR (2) KR100372063B1 (pt)
CN (3) CN1137891C (pt)
AP (1) AP1221A (pt)
AR (2) AR029617A1 (pt)
AT (1) ATE277944T1 (pt)
AU (1) AU764122B2 (pt)
BG (1) BG104175A (pt)
BR (2) BRPI0000967B8 (pt)
CA (1) CA2299495C (pt)
CO (1) CO5160252A1 (pt)
DE (1) DE60014212T2 (pt)
DK (1) DK1031575T3 (pt)
DZ (1) DZ3018A1 (pt)
EA (1) EA003218B1 (pt)
EE (1) EE200000193A (pt)
ES (1) ES2226712T3 (pt)
GT (1) GT200000018A (pt)
HK (1) HK1030219A1 (pt)
HN (1) HN2000000021A (pt)
HR (1) HRP20000103A2 (pt)
HU (1) HUP0000907A3 (pt)
ID (1) ID24861A (pt)
IL (2) IL157103A (pt)
IN (1) IN192352B (pt)
IS (1) IS5380A (pt)
MA (1) MA25072A1 (pt)
NO (1) NO20000965L (pt)
NZ (1) NZ503062A (pt)
OA (1) OA11325A (pt)
PA (1) PA8491201A1 (pt)
PE (1) PE20001550A1 (pt)
PL (1) PL338628A1 (pt)
PT (1) PT1031575E (pt)
SG (1) SG90096A1 (pt)
SI (1) SI1031575T1 (pt)
SK (1) SK284982B6 (pt)
TN (1) TNSN00035A1 (pt)
TR (1) TR200000536A2 (pt)
TW (2) TW200718702A (pt)
UA (1) UA70306C2 (pt)
ZA (1) ZA200000888B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
EP1289526A4 (en) 2000-05-30 2005-03-16 Merck & Co Inc MELANOCORTIN RECEPTOR AGONISTS
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
MX360906B (es) * 2013-05-28 2018-11-21 Raqualia Pharma Inc Forma cristalina del l-tartrato de 2-amino-n[2-(3a-(r)- bencil-2-metil-3-oxo-2,3,3a,4,6,7-hexahidro-pirazolo[4,3-c]piridi n-5-il)-1-(r)-benciloximetil-2-oxo-etil]-isobutiramida.
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
EP0739204A4 (en) 1993-11-09 2000-03-15 Merck & Co Inc PIPERIDINE, PYRROLIDINE AND HEXAHYDRO-1H-AZEPINE SUPPORT THE RELEASE OF THE GROWTH HORMONE
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997036873A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
UA64751C2 (uk) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
JP3514774B2 (ja) 1997-06-25 2004-03-31 ファイザー・インク 成長ホルモン分泌促進薬としてのジペプチド誘導体
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)

Also Published As

Publication number Publication date
HUP0000907A2 (en) 2001-03-28
EA200000172A2 (ru) 2000-08-28
JP2003261565A (ja) 2003-09-19
PL338628A1 (en) 2000-08-28
IL157103A (en) 2007-07-24
EE200000193A (et) 2000-10-16
EP1031575B1 (en) 2004-09-29
PA8491201A1 (es) 2001-04-30
ZA200000888B (en) 2001-08-23
IL134599A (en) 2006-12-10
UA70306C2 (en) 2004-10-15
JP4051314B2 (ja) 2008-02-20
AP1221A (en) 2003-11-03
ES2226712T3 (es) 2005-04-01
HUP0000907A3 (en) 2001-05-28
AR053722A2 (es) 2007-05-16
ID24861A (id) 2000-08-31
IS5380A (is) 2000-08-27
SK284982B6 (sk) 2006-03-02
GT200000018A (es) 2001-08-16
BRPI0017522A2 (pt) 2009-12-22
KR20020065455A (ko) 2002-08-13
BRPI0000967A (pt) 2001-09-11
JP3437813B2 (ja) 2003-08-18
TW200718702A (en) 2007-05-16
BRPI0000967B1 (pt) 2012-06-12
IN192352B (pt) 2004-04-10
CN1270960A (zh) 2000-10-25
NO20000965L (no) 2000-08-28
NO20000965D0 (no) 2000-02-25
ATE277944T1 (de) 2004-10-15
US6541634B2 (en) 2003-04-01
BRPI0000967B8 (pt) 2021-12-07
IL157103A0 (en) 2004-02-08
EP1031575A1 (en) 2000-08-30
SG90096A1 (en) 2002-07-23
CN1137891C (zh) 2004-02-11
EP1449842A1 (en) 2004-08-25
AR029617A1 (es) 2003-07-10
HK1030219A1 (en) 2001-04-27
KR100361783B1 (ko) 2002-11-22
IL134599A0 (en) 2001-04-30
PE20001550A1 (es) 2001-01-11
CO5160252A1 (es) 2002-05-30
EA200000172A3 (ru) 2000-10-30
US20020002283A1 (en) 2002-01-03
MA25072A1 (fr) 2000-10-01
SK2302000A3 (en) 2000-11-07
HU0000907D0 (en) 2000-04-28
TWI286142B (en) 2007-09-01
AP2000001754A0 (en) 2000-03-31
KR100372063B1 (ko) 2003-02-14
HN2000000021A (es) 2001-02-02
KR20010006698A (ko) 2001-01-26
US20030158414A1 (en) 2003-08-21
US6673929B2 (en) 2004-01-06
NZ503062A (en) 2001-07-27
BRPI0017522B8 (pt) 2021-05-25
CA2299495C (en) 2010-06-15
DE60014212D1 (de) 2004-11-04
SI1031575T1 (en) 2005-02-28
EA003218B1 (ru) 2003-02-27
AU764122B2 (en) 2003-08-07
TR200000536A2 (tr) 2000-09-21
CN1515570A (zh) 2004-07-28
AU1947100A (en) 2000-08-31
OA11325A (en) 2003-10-27
HRP20000103A2 (en) 2001-04-30
DE60014212T2 (de) 2005-12-15
DZ3018A1 (fr) 2004-03-20
JP2003327585A (ja) 2003-11-19
TNSN00035A1 (fr) 2005-11-10
CA2299495A1 (en) 2000-08-26
JP2000247974A (ja) 2000-09-12
BRPI0017522B1 (pt) 2013-09-24
CN1837205A (zh) 2006-09-27
DK1031575T3 (da) 2005-01-03
BG104175A (bg) 2000-12-29

Similar Documents

Publication Publication Date Title
PT1105382E (pt) Metodo para a preparacao de citalopran
FI20000564A (fi) Menetelmä nanolaminaattien valmistamiseksi
PT1232152E (pt) Processo melhorado para a preparacao de aminotetralinas substituidas no azoto
PT1147075E (pt) Processo para a preparacao de cloridrato de l-fenilefrina
ITMI992538A0 (it) Processo per la preparazione di catalizzatori zeolitici
PT1154979E (pt) Processo microbiano para a preparacao da pravastatina
PT1031575E (pt) Processo para preparacao de indutores de secrecoes da hormona de crescimento
PT1200414E (pt) Processo para a preparacao de pirimidnas substituidas
PT1228056E (pt) Metodo de preparacao de citaloprame
PT1203000E (pt) Processo para producao de fosfonometilglicina
PT1240173E (pt) Processo para a preparacao de n-fosfonometilglicina
PT1051172E (pt) Metodo para tratamento da dpco
FI19992477A (fi) Menetelmä konjugoidun linolihapon valmistamiseksi
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
PT1159296E (pt) Processo para o fabrico do ciclo-(asp-dphe-nmeval-arggly)
BR0008566B1 (pt) processo para cristalização de n-(4-trifluormetilfenil)-5-metil-isoxazol-4-carboxami da.
DE60002254D1 (de) Verfahren zur Herstellung von 4,6-diaminoresorcin
HUP0202865A3 (en) Process for the preparation of 2-cyanopyridines
IL138691A (en) Process for the preparation of 3-acyl-indoles
PT1212095E (pt) Processo para a preparacao de uma formulacao de libertacao retardada
PT1144382E (pt) Processo para a preparacao de 1,5-diaril-3-(substituido)pirazoles
PT1029867E (pt) Processo para a preparacao de azidas organicas
BR0001550B1 (pt) Processo para preparação de éteres
HK1045989A1 (zh) 尿素製備方法
NO20020328D0 (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol